Clinical trial Recruiting at 1 site Interventional Ages 18 to 80

Investigating protein changes in aging and muscle function

Official title: Skeletal Muscle Myosin Binding Protein C in Fatigue and Aging

Run by University of Oregon · NCT05926219 · Data updated 2026-11-12

This study is trying to see how changes in muscle proteins affect strength and movement in older adults to help improve their recovery and mobility.

Quick facts

Study typeInterventional
Ages18 Years to 80 Years
SexAll
Enrollment24 (estimated)
SponsorUniversity of Oregon
Academic / other
Locations1 site (Eugene, Oregon)
StatusRecruiting
StartedNovember 6, 2017
Main results expectedJanuary 2027
Study endsJanuary 2027
Registry record updatedSeptember 9, 2026
Trial IDNCT05926219 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are healthy adults aged 18-35 or 65-80 who are willing to participate in all aspects of the study.

Probably not a fit

Patients with significant orthopedic limitations, untreated endocrine diseases, or severe chronic conditions may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study examines how changes to proteins in skeletal muscle contribute to muscle atrophy and dysfunction associated with aging. It aims to understand the molecular mechanisms behind age-related muscle decline, which is crucial for enhancing rehabilitation strategies for older adults at risk of mobility impairment. The research involves pre-clinical evidence gathering through interventions like fatiguing exercise and muscle biopsies to identify specific protein modifications that may lead to improved physical function in frail older adults.

Why it matters

Potential benefit: If successful, this study could lead to new strategies for improving physical function and mobility in older adults suffering from muscle weakness and frailty.

How similar studies have gone: While the specific approach of this study may be novel, previous research has indicated that understanding protein changes in muscle can lead to advancements in treating age-related muscle decline.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Adults between the ages 18-35 or 65-80 years
* Healthy by self-report
* Willing to participate in all aspects of the study design including muscle biopsy, unilateral exercise, and physical activity monitoring
* Fluent in English (due to lack of translation services, it is not practical to conduct the study using a language other than English).

Exclusion Criteria:

* Orthopaedic limitation (severe knee osteoarthritis, prior joint replacement, etc.).
* Volunteer has dementia or related mental issues that potentially put the subject at risk as determined by prior diagnosis.
* Volunteer has known untreated endocrine disease (hypo/hyper thyroidism, Addison's Disease or Cushing's syndrome, etc.)
* Volunteer has untreated/poorly-controlled hypertension (stage 2, per American College of Cardiology \[\>140/90 mmHg\]).
* Volunteer has significant heart, liver, kidney or respiratory disease.
* Volunteer has diabetes (insulin dependent or non-insulin dependent).
* Volunteer has known coagulopathies.
* Volunteer has taken anabolic steroids in the prior six months.
* Volunteer has received treatment for cancer (other than effective Mohs Surgery for successful removal of basal cell or squamous cell carcinomas)
* Unexpected weight loss \>5kg is last 12 months
* Volunteer is an active smoker or quit within the last year.
* Volunteer has known current alcohol or drug use disorder (AUD; defined as binge drinking of \>4 days in the last month. Binge drinking is \>5 drinks for men and \>4 drinks for women, per occasion). Or, if a volunteer reports drinking in excess of "low risk" per NIAAA (\>7 drinks/week for men and \>3 drinks/day for women and \>14 drinks/week and \>4 drinks/day).
* Volunteer has a diagnosed neuromuscular disorder.
* Volunteer has allergy to lidocaine.

Where it's running

  • University of Oregon
    Eugene, Oregon, United States
    Recruiting

Study contacts

  • Principal investigator: Damien M Callahan, Ph.D. — University of Oregon
  • Study coordinator: Damien M Callahan, Ph.D.
  • Email: damienc@uoregon.edu
  • Phone: 541-346-5040

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.